There is overwhelming and rapidly increasing evidence for the involvement of MCP-1 in pathophysiological processes that play critical roles in the development of cardiovascular diseases. MCP-1 binds to its receptor and initiates signaling cascade that results in not only chemotaxis but also induction of gene expression changes. The nature of the gene expression changes and their role in pathogenesis are poorly understood. Our research is aimed at filling this void. We discovered that MCP-1 induces the first member of a novel family of CCCH-Zn finger transcription factors, we call MCP-1 induced protein, MCPIP. On the basis of suggestive experimental evidence we postulate that MCPIP and a set of novel genes induced by it are involved in cell death that play a critical role in the development of heart failure. We propose to test this hypothesis. We postulate that MCPIP cause production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) that cause ER stress. Prolonged ER stress caused by sustained expression of MCPIP will lead to autophagy and cell death. Elucidation of the mechanisms by which MCPIP mediates these pathophysiological processes can reveal novel steps suitable for therapeutic intervention in the development of heart failure. To achieve this long term objective we will pursue the following specific aims:
Specific Aim 1. Test the hypothesis that MCPIP induces the production of ROS and RNS that causes ER stress and that the prolonged ER stress resulting from the sustained MCPIP expression leads to autophagy and cell death in cardiomyoblast cell line, H9c2. Identify the key players involved in the progression of these events and validate the key findings in CMC isolated from neonatal hearts.
Specific Aim 2. Test whether the MCPIP mediates production ROS/RNS, ER stress, autophagy and cell death and thus cause development of heart failure in mice. a) Determine whether CMC-targeted expression of MCPIP induces oxidative and ER stress, cell death and heart failure in mice and if it does, determine whether specific inhibitors of ER stress attenuates MCPIP-induced heart failure in MCPIP- mice. b) Determine whether MCPIP knockout attenuates oxidative and ER stress, cell death and the development of heart failure caused by CMC-targeted expression of MCP-1.

Public Health Relevance

Cardiovascular disease is widely recognized as an inflammatory disease. We discovered a novel transcription factor, MCPIP, that is induced by the chemokine, MCP-1. We have evidence that MCPIP plays a critical role in the development of ischemic heart failure. We propose to elucidate the mechanism underlying the role of MCPIP in the development of ischemic heart failure.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56HL069458-06A2
Application #
7899435
Study Section
Cardiac Contractility, Hypertrophy, and Failure Study Section (CCHF)
Program Officer
Schwartz, Lisa
Project Start
2001-09-30
Project End
2011-08-31
Budget Start
2009-09-01
Budget End
2011-08-31
Support Year
6
Fiscal Year
2009
Total Cost
$355,000
Indirect Cost
Name
University of Central Florida
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
150805653
City
Orlando
State
FL
Country
United States
Zip Code
32826
Kapoor, Nidhi; Niu, Jianli; Saad, Yasser et al. (2015) Transcription factors STAT6 and KLF4 implement macrophage polarization via the dual catalytic powers of MCPIP. J Immunol 194:6011-23
Niu, Jianli; Jin, Zhuqing; Kim, Hyunbae et al. (2015) MCP-1-induced protein attenuates post-infarct cardiac remodeling and dysfunction through mitigating NF-?B activation and suppressing inflammation-associated microRNA expression. Basic Res Cardiol 110:26
Garg, Abhishek V; Amatya, Nilesh; Chen, Kong et al. (2015) MCPIP1 Endoribonuclease Activity Negatively Regulates Interleukin-17-Mediated Signaling and Inflammation. Immunity 43:475-87
Jin, Zhuqing; Liang, Jian; Wang, Jing et al. (2015) MCP-induced protein 1 mediates the minocycline-induced neuroprotection against cerebral ischemia/reperfusion injury in vitro and in vivo. J Neuroinflammation 12:39
Niu, Jianli; Gilliland, M G F; Jin, Zhuqing et al. (2014) MCP-1and IL-1? expression in the myocardia of two young patients with Type 1 diabetes mellitus and fatal diabetic ketoacidosis. Exp Mol Pathol 96:71-9
Niu, Jianli; Wang, Kangkai; Zhelyabovska, Olga et al. (2013) MCP-1-induced protein promotes endothelial-like and angiogenic properties in human bone marrow monocytic cells. J Pharmacol Exp Ther 347:288-97
Jin, Zhuqing; Liang, Jian; Wang, Jing et al. (2013) Delayed brain ischemia tolerance induced by electroacupuncture pretreatment is mediated via MCP-induced protein 1. J Neuroinflammation 10:63
Roy, Arpita; Zhang, Miaojun; Saad, Yasser et al. (2013) Antidicer RNAse activity of monocyte chemotactic protein-induced protein-1 is critical for inducing angiogenesis. Am J Physiol Cell Physiol 305:C1021-32
Roy, Arpita; Kolattukudy, Pappachan E (2012) Monocyte chemotactic protein-induced protein (MCPIP) promotes inflammatory angiogenesis via sequential induction of oxidative stress, endoplasmic reticulum stress and autophagy. Cell Signal 24:2123-31
Younce, Craig; Kolattukudy, Pappachan (2012) MCP-1 induced protein promotes adipogenesis via oxidative stress, endoplasmic reticulum stress and autophagy. Cell Physiol Biochem 30:307-20

Showing the most recent 10 out of 21 publications